Case number 2020-1552
Takeda Pharmaceutical Company v. Torrent Pharmaceuticals Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | TAKEDA PHARMACEUTICAL COMPANY v. TORRENT PHARMACEUTICALS LTD. [OPINION] [nonprecedential] (0) |
| Feb 16, 2021 | 67 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [756134] [20-1552, 20-1598] [JCP] [Entered: 02/16/2021 09:54 AM] (2) |
| Feb 16, 2021 | 66 | OPINION filed for the court by Dyk, Circuit Judge; Mayer, Circuit Judge and Chen, Circuit Judge. Nonprecedential Opinion. [756133] [20-1552, 20-1598] [JCP] [Entered: 02/16/2021 09:52 AM] (8) |
| Feb 5, 2021 | 65 | Submitted after ORAL ARGUMENT to Panel: Dyk, Circuit Judge; Mayer, Circuit Judge and Chen, Circuit Judge.Arguing counsel: Mr. Ivan Michael Poullaos for Indoco Remedies Ltd., Mr. H. Keeto Sabharwal, Esq. for Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd. and Mr. Gregory A. Castanias for Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Ireland Limited.Oral Argument Audio available here. [754240] [JCP] [Entered: 02/05/2021 03:27 PM] (0) |
| Jan 15, 2021 | 64 | Response to notice of oral argument from Appellees Takeda Ireland Limited, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 01/15/2021 by email. [749820] [20-1552] [Gregory Castanias] [Entered: 01/15/2021 02:49 PM] (1) |
| Jan 15, 2021 | 63 | Clerk's letter to Appellants Indoco Remedies Ltd., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd. and Appellees Takeda Ireland Limited, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc. regarding Telephonic Argument Orientation. Service as of this date by the Clerk of Court. [749797] [JAB] [Entered: 01/15/2021 02:18 PM] (0) |
| Jan 14, 2021 | 62 | Corrected Response to notice of oral argument from Appellant Indoco Remedies Ltd.. Service: 01/14/2021 by email. [749599] [20-1552] [Ivan Poullaos] [Entered: 01/14/2021 05:00 PM] (1) |
| Jan 14, 2021 | 61 | Response to notice of oral argument from Appellants Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.. Service: 01/14/2021 by email. [749541] [20-1552] [H. Sabharwal] [Entered: 01/14/2021 02:28 PM] (1) |
| Jan 13, 2021 | 60 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [59], ERROR: Counsel for appellant Indoco Remedies Ltd. submitted a Response to Notice of Oral Argument indicating 5 minutes for argument and 2.5 minutes for rebuttal. CORRECTION: Time may not be divided into half minutes. Please promptly file a corrected response. [749312] [JAB] [Entered: 01/13/2021 04:10 PM] (0) |
| Jan 13, 2021 | 59 | Response to notice of oral argument from Appellant Indoco Remedies Ltd.. Service: 01/13/2021 by email. [749155] [20-1552] [Ivan Poullaos] [Entered: 01/13/2021 02:00 PM] (1) |
| Dec 18, 2020 | 58 | NOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2102L. Case scheduled February 5, 2021. Response to Notice of Oral Argument due: 01/15/2021. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [743989] [JAB] [Entered: 12/18/2020 04:01 PM] (1) |
| Dec 11, 2020 | 57 | 6 paper copies of Doc. Nos. [25], [37] received from Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd. [742511]--[Edited 01/21/2021 by MJL to correct party filers and link correct documents] [VDW] [Entered: 12/14/2020 03:13 PM] (0) |
| Dec 7, 2020 | 56 | NOTICE OF NON-COMPLIANCE: The paper copies (Doc. No. [54]) filed by Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd. are not in compliance with the rules of this court (see attached). Compliant paper copies due 12/14/2020. Service as of this date by the Clerk of Court. [740851] [MJL] [Entered: 12/07/2020 05:49 PM] (1) |
| Dec 2, 2020 | 55 | 6 paper copies of Doc. Nos. [28], [36], [50] received from Indoco Remedies Ltd. [740850] [MJL] [Entered: 12/07/2020 05:46 PM] (0) |
| Nov 30, 2020 | 54 | 6 paper copies of Doc. Nos. [25], [37] received from Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd. [740846]. These paper copies are non-compliant. See Doc. No. [56]. [MJL] [Entered: 12/07/2020 05:38 PM] (0) |
| Nov 30, 2020 | 53 | 6 paper copies of Doc. No. [31] received from Appellees Takeda Ireland Limited, Takeda Pharmaceutical Company Ltd., et al. [740845] [MJL] [Entered: 12/07/2020 05:34 PM] (0) |
| Nov 30, 2020 | 52 | Notice from Appellees Takeda Ireland Limited, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc. regarding conflicts with oral argument. None. Service: 11/30/2020 by email. [738939] [20-1552] [Gregory Castanias] [Entered: 11/30/2020 05:21 PM] (1) |
| Nov 25, 2020 | 51 | Notice from Appellants Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd. regarding conflicts with oral argument. None. Service: 11/25/2020 by email. [738490] [20-1552] [H. Sabharwal] [Entered: 11/25/2020 03:25 PM] (1) |
| Nov 24, 2020 | 50 | MODIFIED ENTRY: CORRECTED APPENDIX FILED by Appellant Indoco Remedies Ltd.. Service: 11/24/2020 by email. [738226]--[Edited 11/25/2020 by KMH - compliance review complete] [Ivan Poullaos] [Entered: 11/24/2020 05:47 PM] (2033) |
| Nov 24, 2020 | 49 | Notice of Correction to Doc No. [45] for Appellant Indoco Remedies Ltd.. Service: 11/24/2020 by email. [738218] [20-1552] [Ivan Poullaos] [Entered: 11/24/2020 05:30 PM] (2) |
| Nov 23, 2020 | 48 | MODIFIED ENTRY: Notice from Indoco Remedies Ltd. regarding conflicts with oral argument. None. Service: 11/23/2020 by email. [737835]--[Edited 11/24/2020 by MJL to correct filing event] [Ivan Poullaos] [Entered: 11/23/2020 05:30 PM] (1) |
| Nov 19, 2020 | 47 | Notice to counsel: The Clerk's Office directs that outstanding paper copies of all briefs and appendices in this case must be submitted on or before December 3, 2020. See Administrative Order No. 20-01 (Mar. 20, 2020). [737000] [KMH] [Entered: 11/19/2020 02:41 PM] (0) |
| Nov 19, 2020 | 46 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [736997] [KMH] [Entered: 11/19/2020 02:38 PM] (1) |
| Nov 17, 2020 | 45 | MODIFIED ENTRY: CORRECTED APPENDIX FILED by Appellant Indoco Remedies Ltd. Service: 11/17/2020 by email. [736393] --[Edited 11/19/2020 by KMH - compliance review complete] This document has been corrected. See Doc No. [50] [Ivan Poullaos] [Entered: 11/17/2020 03:00 PM] (2033) |
| Nov 13, 2020 | 44 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Indoco Remedies Ltd., Appendix [39], is not in compliance with the rules of this court (see attached). Compliant document due on 11/20/2020. Service as of this date by the Clerk of Court. [735373] [KMH] [Entered: 11/13/2020 12:13 PM] (2) |
| Oct 15, 2020 | 42 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellees Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Ireland Limited and Takeda Pharmaceuticals U.S.A., Inc.. Service: 10/15/2020 by email. [729231] [20-1552] [Gregory Castanias] [Entered: 10/15/2020 10:18 PM] (2) |
| Oct 15, 2020 | 41 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellants Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.. Service: 10/15/2020 by email. [729217] [20-1552] [H. Sabharwal] [Entered: 10/15/2020 05:56 PM] (3) |
| Oct 15, 2020 | 40 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Indoco Remedies Ltd., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd. and Appellees Takeda Ireland Limited, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 10/15/2020 by email. [729216] [20-1552] [H. Sabharwal] [Entered: 10/15/2020 05:54 PM] (5) |
| Oct 15, 2020 | 39 | APPENDIX FILED by Appellant Indoco Remedies Ltd.. Service: 10/15/2020 by email. [729212] [20-1552] This document is non-compliant. See Doc No. [44] [Ivan Poullaos] [Entered: 10/15/2020 05:44 PM] (2033) |
| Oct 15, 2020 | 38 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellant Indoco Remedies Ltd.. Service: 10/15/2020 by email. [729206] [20-1552] [Ivan Poullaos] [Entered: 10/15/2020 05:16 PM] (1) |
| Oct 8, 2020 | 37 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellants Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.. Service: 10/08/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [727749] --[Edited 10/22/2020 by KMH - compliance review complete] [H. Sabharwal] [Entered: 10/08/2020 05:39 PM] (35) |
| Oct 8, 2020 | 36 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Indoco Remedies Ltd.. Service: 10/08/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [727715] --[Edited 10/22/2020 by KMH - compliance review complete] [Ivan Poullaos] [Entered: 10/08/2020 04:29 PM] (38) |
| Oct 7, 2020 | 35 | Amended Certificate of Interest for Appellant Indoco Remedies Ltd.. Service: 10/07/2020 by email. [727382] [20-1552] [Ivan Poullaos] [Entered: 10/07/2020 01:37 PM] (2) |
| Sep 18, 2020 | 34 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [32], ERROR: The Certificates of Interest are incomplete. The filing does not include a certificate of compliance with the word count. CORRECTION: For future filings, please include Question #6 on the Certificate of Interest. For future filings, please include a certificate of compliance stating the exact word count. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [722699] [EKD] [Entered: 09/18/2020 09:31 AM] (0) |
| Sep 18, 2020 | 33 | **TEXT ONLY** ORDER granting motion to extend time to file brief [32] filed by Appellants Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., and Indoco Remedies Ltd. The reply brief is due 10/08/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [722698] [EKD] [Entered: 09/18/2020 09:29 AM] (0) |
| Sep 15, 2020 | 32 | MOTION of Appellants Indoco Remedies Ltd., Torrent Pharmaceuticals Ltd. and Torrent Pharma Inc. to extend the time to 10/08/2020 to file brief. [Consent: unopposed]. Service: 09/15/2020 by email. [721699] [20-1552] [H. Sabharwal] [Entered: 09/15/2020 12:41 PM] (9) |
| Sep 3, 2020 | 31 | MODIFIED ENTRY: RESPONSE BRIEF FILED for Appellees Takeda Ireland Limited, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc. Number of Pages: 63. Service: 09/03/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [719549] --[Edited 09/04/2020 by LMN - compliance review complete] [Gregory Castanias] [Entered: 09/03/2020 08:58 PM] (77) |
| Jul 16, 2020 | 30 | **TEXT ONLY** ORDER granting motion to extend time to file brief [29] filed by Appellees Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Ireland Limited. The response brief is due 09/03/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [708070] [LMN] [Entered: 07/16/2020 01:22 PM] (0) |
| Jul 16, 2020 | 29 | MOTION of Appellees Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Ireland Limited and Takeda Pharmaceuticals U.S.A., Inc. to extend the time to 09/03/2020 to file the Appellees' opposition brief. [Consent: unopposed]. Service: 07/16/2020 by email. [707975] [20-1552] [Gregory Castanias] [Entered: 07/16/2020 11:10 AM] (10) |
| Jul 7, 2020 | 28 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED for Appellant Indoco Remedies Ltd. Number of Pages: 63. Service: 07/07/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [705863] --[Edited 07/07/2020 by LMN - compliance review complete] [Ivan Poullaos] [Entered: 07/07/2020 01:51 PM] (198) |
| Jul 7, 2020 | 27 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Indoco Remedies Ltd., Opening Brief [26], is not in compliance with the rules of this court (see attached). Compliant document is due on 07/14/2020. Service as of this date by the Clerk of Court. [705809] [LMN] [Entered: 07/07/2020 11:46 AM] (2) |
| Jun 25, 2020 | 26 | FILED from Appellant Indoco Remedies Ltd.. Title: OPENING BRIEF. Service: 06/25/2020 by email. This document has been corrected. See doc. [28] [703820] [20-1552] This document is non-compliant. See Doc No. [27]--[Edited 07/07/2020 by LMN] [Ivan Poullaos] [Entered: 06/25/2020 06:49 PM] (198) |
| Jun 25, 2020 | 25 | MODIFIED ENTRY: OPENING BRIEF FILED for Appellants Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd. Number of Pages: 47. Service: 06/25/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [703818] --[Edited 06/30/2020 by LMN - compliance review complete] [H. Sabharwal] [Entered: 06/25/2020 06:28 PM] (183) |
| May 7, 2020 | 24 | **TEXT ONLY** ORDER granting motion to extend time to file brief [21] filed by Appellants Torrent Pharma Inc., Torrent Pharmaceuticals Ltd. and Indoco Remedies Ltd. The opening briefs are due 06/25/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [692695] [LMN] [Entered: 05/07/2020 08:15 AM] (0) |
| Apr 30, 2020 | 23 | Certificate of Interest for Appellants Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.. Service: 04/30/2020 by email. [691397] [20-1552] [H. Sabharwal] [Entered: 04/30/2020 03:41 PM] (3) |
| Apr 30, 2020 | 22 | DECLARATION of Keeto Sabharwal IN SUPPORT OF MOTION FOR 30-DAY EXTENSION OF TIME TO FILE OPENING BRIEFS for Appellants Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.. Service: 04/20/2020 by email. [691391] [20-1552] [H. Sabharwal] [Entered: 04/30/2020 03:34 PM] (3) |
| Apr 30, 2020 | 21 | MOTION of Appellants Indoco Remedies Ltd., Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd. to extend the time to 06/25/2020 to file the Opening Briefs. [Consent: unopposed]. Service: 04/30/2020 by email. [691353] [20-1552] [Ivan Poullaos] [Entered: 04/30/2020 03:10 PM] (10) |
| Apr 23, 2020 | 20 | Docketing Statement for the Appellant Indoco Remedies Ltd.. Service: 04/23/2020 by email. [689466] [20-1552] [Ivan Poullaos] [Entered: 04/23/2020 11:43 AM] (4) |
| Apr 22, 2020 | 19 | Entry of appearance for John R. McNair as of counsel for Indoco Remedies Ltd.. Service: 04/22/2020 by email. [689264] [20-1552] [John McNair] [Entered: 04/22/2020 04:05 PM] (2) |
| Apr 22, 2020 | 18 | Entry of appearance for George Lombardi as of counsel for Indoco Remedies Ltd.. Service: 04/22/2020 by email. [689260] [20-1552] [George Lombardi] [Entered: 04/22/2020 04:02 PM] (2) |
| Apr 22, 2020 | 17 | Entry of appearance for Alison M. Heydorn as of counsel for Indoco Remedies Ltd.. Service: 04/22/2020 by email. [689258] [20-1552] [Alison Heydorn] [Entered: 04/22/2020 03:59 PM] (2) |
| Apr 22, 2020 | 16 | Certificate of Interest for Indoco Remedies Ltd.. Service: 04/22/2020 by email. [689256] [20-1552] [Ivan Poullaos] [Entered: 04/22/2020 03:53 PM] (3) |
| Apr 22, 2020 | 15 | Entry of appearance for Ivan Poullaos as principal counsel for Indoco Remedies Ltd.. Service: 04/22/2020 by email. [689254] [20-1552] [Ivan Poullaos] [Entered: 04/22/2020 03:50 PM] (2) |
| Apr 6, 2020 | 14 | Note to file: The following cases are associated: 20-1552 Lead with 20-1598 Cross-Appeal. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [684342] [20-1552, 20-1598] [LMN] [Entered: 04/06/2020 11:24 AM] (0) |
| Apr 6, 2020 | 13 | ORDER consolidating appeals 20-1552 with 20-1598. The opening brief of both appellants is due no later than May 26, 2020. Service as of this date by the Clerk of Court. [684340] [20-1552, 20-1598] [LMN] [Entered: 04/06/2020 11:22 AM] (2) |
| Mar 27, 2020 | 12 | REMINDER: Attorneys Yun Wei and Jason Winchester are reminded that the information on the Entry of Appearance (EOA) and the information in the user account must match. Please promptly update the EOA or the account information on www.pacer.gov. [682327] [LMN] [Entered: 03/27/2020 12:13 PM] (0) |
| Mar 26, 2020 | 11 | Docketing Statement for the Appellees Takeda Ireland Limited, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 03/26/2020 by email. [682206] [20-1552] [Gregory Castanias] [Entered: 03/26/2020 09:07 PM] (3) |
| Mar 26, 2020 | 10 | Certificate of Interest for Appellees Takeda Ireland Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Pharmaceutical Company Ltd.. Service: 03/26/2020 by email. [682205] [20-1552] [Gregory Castanias] [Entered: 03/26/2020 09:03 PM] (2) |
| Mar 26, 2020 | 9 | Entry of appearance for Lisamarie LoGiudice as of counsel for Appellees Takeda Ireland Limited, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 03/26/2020 by email. [682203] [20-1552] [Gregory Castanias] [Entered: 03/26/2020 08:59 PM] (1) |
| Mar 26, 2020 | 8 | Entry of appearance for Jason G. Winchester as of counsel for Appellees Takeda Ireland Limited, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 03/26/2020 by email. [682202] [20-1552] [Gregory Castanias] [Entered: 03/26/2020 08:56 PM] (1) |
| Mar 26, 2020 | 7 | Entry of appearance for Gregory A. Castanias as principal counsel for Appellees Takeda Ireland Limited, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 03/26/2020 by email. [682201] [20-1552] [Gregory Castanias] [Entered: 03/26/2020 08:51 PM] (1) |
| Mar 26, 2020 | 6 | Entry of appearance for Cedric Chia Yang Tan as of counsel for Appellants Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.. Service: 03/26/2020 by email. [682120] [20-1552] [Cedric Tan] [Entered: 03/26/2020 03:15 PM] (1) |
| Mar 26, 2020 | 5 | Certificate of Interest for Appellants Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.. Service: 03/26/2020 by email. [682113] [20-1552] [H. Sabharwal] [Entered: 03/26/2020 03:09 PM] (2) |
| Mar 26, 2020 | 4 | Docketing Statement for the Appellants Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.. Service: 03/26/2020 by email. [682106] [20-1552] [H. Sabharwal] [Entered: 03/26/2020 03:06 PM] (4) |
| Mar 26, 2020 | 3 | Entry of appearance for H. Keeto Sabharwal as principal counsel for Appellants Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.. Service: 03/26/2020 by email. [682103] [20-1552] [H. Sabharwal] [Entered: 03/26/2020 03:03 PM] (1) |
| Mar 26, 2020 | 2 | Entry of appearance for Yun Wei as of counsel for Appellants Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd.. Service: 03/26/2020 by email. [682015] [20-1552] [Yun Wei] [Entered: 03/26/2020 01:13 PM] (2) |
| Mar 12, 2020 | 1 | Appeal docketed. Received: 03/02/2020. [678139]Entry of Appearance is due 03/26/2020. Certificate of Interest is due on 03/26/2020. Docketing Statement is due 03/26/2020. Appellant's brief is due 05/11/2020. [LMN] [Entered: 03/12/2020 10:14 AM] (87) |
